VaxInnate Enhances R&D Program and Strengthens Senior Management Team to Drive Pipeline Development of Current and Potential Targets Cranbury, NJ, May 13, 2015 (GLOBE NEWSWIRE) -- VaxInnate Corporation, a biotechnology firm pioneering a breakthrough vaccine technology, today announced two strategic promotions and two additions to...

Melinta Therapeutics Bolsters Board of Directors with Appointment of Christopher Kiritsy NEW HAVEN, Conn, Aug. 14, 2014 (GLOBE NEWSWIRE) -- Melinta Therapeutics today announced the appointment of Christopher Kiritsy to the Company's Board of Directors. Mr. Kiritsy is currently president,...